Waters Corporation

Waters Corporation

WAT·NYSE

$379.77

+2.1%
HealthcareMedical - Diagnostics & Research

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

At a Glance

Live Snapshot
Market Cap$24.75B
EPS10.8000
P/E Ratio35.16
Earnings Date08/03/2026
14.96%
Return on Invested Capital
-19%
3Y-48.0%
5Y-40.0%
10Y+17.0%
25.09%
Return on Equity
-28%
3Y-82.0%
5Y-89.0%
10Y+11.0%
12.64%
Return on Assets
-10%
3Y-41.0%
5Y-31.0%
10Y+13.0%
Waters Corporation

Waters Corporation Management Team

WAT · NYSE
MC

Mr. Caspar Tudor

Head of Investor Relations

male
DU

Dr. Udit Batra Ph.D.

President, Chief Executive Officer & Director

Compensation

$2,321,419

Born 1971(Age 55)
MA

Mr. Amol Chaubal

Senior Vice President & Chief Financial Officer

Compensation

$985,863

Born 1976(Age 50)
male
MC

Mr. Christos Ross

Senior Vice President of Global Operations

male
MC

Ms. Cheryl Kennedy

Senior Vice President of Human Resources

female
DD

Dr. Daniel Rush Ph.D.

Senior Vice President of Strategy & Transformation

MJ

Ms. Jianqing Y. Bennett

Senior Vice President of TA Instruments Division & Waters Clinical Business Unit

Compensation

$996,751

Born 1970(Age 56)
female
MR

Mr. Robert L. Carpio III

Senior Vice President of Waters Division

Compensation

$648,848

Born 1983(Age 43)
male
MK

Ms. Keeley A. Aleman J.D.

Senior Vice President, General Counsel & Corporate Secretary

Compensation

$897,333

Born 1977(Age 49)
female
MK

Ms. Kristen Garvey

Vice President of Corporate Communications

female
wat

Waters Corporation Insider Positioning

WAT · NYSE

During the last 12 months, insiders have purchased $451K worth of WAT shares, with no selling activity reported.

3 Months

Bought

1.5K

451.07K

Sold

0

0.00

Net Activity

+451K

+$451K

3-6 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

6-9 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

9-12 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

Top Buyers

1
FRH

Fearon Richard H

Director

1.0K shares1 transactions

$306K

2
JW

Jiang Wei

Director

500 shares1 transactions

$145K

Top Sellers

No selling activity

Insider Activity Analysis

Net Insider Sentiment

Bullish

Strong bullish signal with $451K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.

Buy/Sell Ratio

∞:1

Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.

Recent Trend (3 Months)

$451K

Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.

Insider Participation

High Buying

2 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.

Insider Activity Insight

Compelling insider conviction: The combination of strong buy/sell ratio and multiple buyers suggests insiders see attractive risk/reward. Consider this alongside fundamental analysis for confirmation.

SEC Filings

WAT - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
DEF 14A

DEF 14A 2026

N/A

April 09, 2026
May 21, 2026
2026
DEF 14A

DEF 14A 2025

N/A

April 09, 2025
May 22, 2025
2025
DEF 14A

DEF 14A 2024

N/A

April 12, 2024
May 23, 2024
2024
DEF 14A

DEF 14A

N/A

April 13, 2023
April 13, 2023
 
DEF 14A

DEF 14A 2022

N/A

April 14, 2022
May 24, 2022
2022
DEF 14A

DEF 14A 2021

N/A

April 01, 2021
May 11, 2021
2021
DEF 14A

DEF 14A 2020

N/A

April 02, 2020
May 12, 2020
2020
DEF 14A

DEF 14A 2019

N/A

April 04, 2019
May 14, 2019
2019
DEF 14A

DEF 14A 2018

N/A

March 29, 2018
May 09, 2018
2018
DEF 14A

DEF 14A 2017

N/A

March 29, 2017
May 09, 2017
2017
Showing 1 to 10 of 30 filings